logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Avidity Biosciences, Inc.


USPTO Granted Patents = 54



Forward Citations = 387

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Rob Burke (41 out of 44 patents)

silverMedal Venkata Ramana Doppalapudi (37 out of 44 patents)

bronzeMedal Beatrice Diana Darimont (37 out of 37 patents)

4.  Michael Caramian Cochran (35 out of 37 patents)

5.  Barbora Malecova (27 out of 27 patents)

6.  Andrew John Geall (25 out of 101 patents)

7.  David Sai-Ho Chu (21 out of 21 patents)

8.  Yunyu Shi (15 out of 15 patents)

9.  Gulin Erdogan Marelius (14 out of 19 patents)

10.  Michael David Hood (14 out of 14 patents)

11.  David Sala Cano (10 out of 10 patents)

12.  Rachel Elizabeth Johns (9 out of 9 patents)

13.  Hanhua Huang (8 out of 8 patents)

14.  Palani Balu (6 out of 14 patents)

15.  Arthur A Levin (5 out of 5 patents)


Core Competencies:
Polynucleotide Conjugates
Anti-Transferrin Receptor Antibodies
Muscle Dystrophy
Exon Skipping
Nucleic Acid Compositions
Facioscapulohumeral Dystrophy
Myotonic Dystrophy
Cardiomyopathy
Nucleic Acid-Polypeptide Compositions
PRKAG2-Targeting Antibodies
DMD Exon 44 Skipping
Compositions and Methods

54 patents:

1. 12708669 - POLYNUCLEOTIDE CONJUGATES COMPRISING PLN-TARGETING POLYNUCLEOTIDES AND ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND METHOD OF USE THEREOF TO TREAT PLN-ASSOCIATED CARDIOMYOPATHIES (2026-08-18),
2. 12648999 - COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY (2026-06-09),
3. 12648998 - ANTI-TRANSFERRIN RECEPTOR ANTIBODY-PMO CONJUGATES FOR INDUCING DMD EXON 44 SKIPPING (2026-06-09),
4. 12529056 - COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (2026-01-20),
5. 12497615 - NUCLEIC ACID COMPOSITIONS AND METHODS OF MULTI-EXON SKIPPING (2025-12-16),
6. 12491257 - COMPOSITIONS AND METHODS OF USING PRKAG2-TARGETING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES (2025-12-09),
7. 12486328 - COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (2025-12-02),
8. 12427202 - Compositions and methods of treating muscle dystrophy (2025-09-30),
9. 12409230 - Compositions comprising PLN-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathy (2025-09-09),
10. 12365704 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-22),
11. 12364769 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-22),
12. 12359202 - Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping (2025-07-15),
13. 12351637 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-08),
14. 12263224 - Compositions and methods of treating muscle atrophy and myotonic dystrophy (2025-04-01),
15. 12234290 - Nucleic acid-polypeptide compositions and uses thereof (2025-02-25),
Avidity Biosciences, Inc. is a biotechnology company based in San Diego, CA, specializing in nucleic acid therapeutics. The company focuses on developing innovative treatments using polynucleotide conjugates and anti-transferrin receptor antibodies. Avidity's research addresses various muscle disorders, including muscle dystrophies, facioscapulohumeral dystrophy, myotonic dystrophy, and cardiomyopathy, aiming to advance therapeutic options through its proprietary technology platform.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Avidity Biosciences, Inc.
54 Patents

#114 in San Diego, CA

#1,541 in California

#6,549 in US

#13,100 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Avidity Biosciences, Inc.

Forward Citations = 387

26 inventors:

goldMedal Rob Burke (41 out of 44 patents)

silverMedal Venkata Ramana Doppalapudi (37 out of 44 patents)

bronzeMedal Beatrice Diana Darimont (37 out of 37 patents)

4.  Michael Caramian Cochran (35 out of 37 patents)

5.  Barbora Malecova (27 out of 27 patents)

Please report any incorrect information to [email protected]
Loading…